Of note, the V2 isoform only comprises less than 5% of total PRMT1 level, but V2 is mainly responsible for oncogenic activities in colon and breast cancers (Baldwin et al., 2012; Papadokostopoulou et al., 2009). This evidence concerns the gene PRMT1 and breast carcinoma.